Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
GW Pharmaceuticals
GW Pharmaceuticals
Activities:
Ingredients
Research & Development
X
LinkedIn
Trending Articles
The perfect pair: how vitamins K2 and D3 combine to support health and well-being
Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
Grøntvedt omega-11 production capacity expands
The company has expanded its omega-11 manufacturing capabilities by around 50% at its Uthaug site
ADM’s gut health probiotic approved by the Chinese NHC
DE111, ADM’s proprietary spore-forming probiotic, has been certified by the National Health Commission in China
NutriLeads’ Benicaros can uplift gut health, study finds
The precision prebiotic enhances the abundance of beneficial bacteria essential for a stable gut ecosystem
From subscriptions to mushrooms: BCMPA members discuss the latest outsourcing trends in nutraceuticals
From single-serve sachets catering to the busy on-the-go market to specialised subscription models shaping direct-to-consumer interactions, the nutraceutical industry is...
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Finance
GW Pharmaceuticals reports Epidiolex sales of $296 million in first year
The British biopharmaceutical company has released Q4 and 2019 financial year results
Manufacturing
Momentum in the US cannabidiol market gains retailers' attention
Walmart and other big-name stores in talks with food and drinks makers in preparation for the day CBD-enriched products are allowed on the shelves
Regulatory
First prescription CBD from GW Pharma has restriction lowered
The US Drug Enforcement Administration’s decision to move Epidiolex to Schedule V was based on non-clinical and clinical data that evaluated the medicine’s potential for abuse
Ingredients
Marijuana derivative reduces seizures in children and young adults with treatment-resistant epilepsy
New open-label trial of prescription cannabidiol shows overall safety and efficacy
Subscribe now